Altamira Therapeutics News

Altamira Therapeutics Announces Publication of Positive Results From Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio trial in seasonal allergic rhinitis published in Allergy journal Study met primary efficacy

Altamira TherapeuticsApr 24 00:00 ET

Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on April 18, 2024

NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its Spotlight Investor Conference on April 18, 2024. The

GlobeNewswireApr 17 08:00 ET

Altamira Therapeutics Announces 2024 Annual Meeting

TipRanksApr 16 17:57 ET

Diamond Equity Research Initiates Coverage on Altamira Therapeutics Ltd. (NASDAQ: CYTO)

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Altamira Therapeutics Ltd.

GlobeNewswireApr 15 08:00 ET

Express News | Altamira Therapeutics FY EPS $(16.47) Sales $284.47K Down From $330.37K YoY

Moomoo 24/7Apr 10 09:21 ET

Express News | Altamira Therapeutics FY GAAP EPS CHF(14.80) Up From CHF(409.60) YoY, Other Operating Income CHF255.59K Up From CHF9.33K YoY

Moomoo 24/7Apr 10 08:06 ET

Altamira Therapeutics 2023 Loss/Shr CHF7.88 >CYTO

Altamira Therapeutics 2023 Loss/Shr CHF7.88 >CYTO

Dow JonesApr 10 08:02 ET

Earnings Scheduled For April 10, 2024

Companies Reporting Before The Bell • Delta Air Lines (NYSE:DAL) is projected to report quarterly earnings at $0.35 per share on revenue of $12.55 billion. • Altamira Therapeutics (NASDAQ:CYTO) is est

BenzingaApr 10 05:18 ET

Notable Earnings Before Wednesday's Open

Seeking AlphaApr 9 09:33 ET

Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024

Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA del

Altamira TherapeuticsApr 4 00:00 ET

Sector Update: Health Care Stocks Softer in Afternoon Trading

Health care stocks were easing Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding about 0.2%. The iShares Biotechnology ETF (IBB) decreas

MT NewswiresMar 25 14:01 ET

Crude Oil Moves Higher; US New Home Sales Fall In February

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow traded down 0.22% to 39,389.17 while the NASDAQ fell 0.15% to 16,410.10. The S

BenzingaMar 25 11:54 ET

Why Altamira Therapeutics Stock Is Racing Higher

Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares are trading higher Monday after the company announced that it has entered into a collaboration agreement with Univercells Group to evaluate the use of t

BenzingaMar 25 11:38 ET

Nkarta, Nuvation Bio, Canopy Growth Among Healthcare Movers

Seeking AlphaMar 25 10:00 ET

US Stocks Down; Chicago Fed National Activity Index Rises In February

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 50 points on Monday. Following the market opening Monday, the Dow traded down 0.16% to 39,412.36 while the NASDAQ fell

BenzingaMar 25 09:42 ET

Express News | Altamira Therapeutics Shares Are Trading Higher After the Company Announced a Collaboration With Univercells Group on Nanoparticle-delivered MRNA Vaccines

Moomoo 24/7Mar 25 09:34 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

GainersLandos Biopharma (NASDAQ:LABP) shares moved upwards by 181.6% to $22.05 during Monday's pre-market session. The market value of their outstanding shares is at $68.7 million. As per the press re

BenzingaMar 25 09:05 ET

Express News | Altamira Therapeutics Announces Collaboration With Univercells Group To Evaluate Use Of SemaPhore Platform For The Delivery Of MRNA Vaccines

Moomoo 24/7Mar 25 08:48 ET

Altamira Therapeutics Announces Collaboration With Univercells Group on Nanoparticle-Delivered MRNA Vaccines

HAMILTON, BERMUDA, March 25, 2024 (GLOBE NEWSWIRE) -- Univercells to test proprietary mRNA vaccine delivered with Altamira's SemaPhore nanoparticlesTargeting safer and accessible mRNA vaccinesAltami

Altamira TherapeuticsMar 25 00:00 ET

Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals Among Healthcare Movers

Seeking AlphaMar 4 10:00 ET